Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

987
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
987
Neural Regulation01:37

Neural Regulation

43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.4K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical applications of digital twin technology in In Vitro Fertilisation.

Journal of gynecology obstetrics and human reproduction·2026
Same author

Translational Gaps in Immuno-AI: From algorithmic accuracy to clinical trust.

Human immunology·2026
Same author

Mitigating algorithmic bias in AI-powered toxicology: Frameworks for explainable and equitable predictions in human health and environmental safety.

Toxicology letters·2026
Same author

Polygenic risk scores for cardiovascular disease: clinical utility and limitations.

The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology·2026
Same author

Digital twins in urological oncology and surgery: A review of emerging applications.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Digital twin technology in forensic mental health.

Journal of forensic and legal medicine·2026

Related Experiment Video

Updated: Jan 17, 2026

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.5K

Explainable AI for Parkinson's disease prediction: A machine learning approach with interpretable models.

Adebimpe O Esan1, David B Olawade2, Afeez A Soladoye1

  • 1Department of Computer Engineering, Federal University, Oye-Ekiti, Nigeria.

Current Research in Translational Medicine
|September 13, 2025
PubMed
Summary

This study developed an interpretable machine learning model for accurate Parkinson's Disease (PD) prediction. Explainable AI techniques identified key predictors, improving early diagnosis and patient care.

Keywords:
Clinical decision-makingExplainable artificial intelligenceMachine learningParkinson’s diseasePredictive modeling

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.3K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K

Related Experiment Videos

Last Updated: Jan 17, 2026

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.5K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.3K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K

Area of Science:

  • Neurology
  • Artificial Intelligence
  • Data Science

Background:

  • Parkinson's Disease (PD) presents diagnostic challenges due to its progressive nature and limitations of traditional methods.
  • Machine Learning (ML) offers potential for early PD prediction, but interpretability issues hinder clinical use.
  • Explainable Artificial Intelligence (XAI) is crucial for bridging the gap between ML models and clinical practice.

Purpose of the Study:

  • To develop an interpretable ML model for early and accurate PD prediction.
  • To utilize multimodal datasets and XAI techniques for enhanced diagnostic capabilities.
  • To improve clinical decision-making and patient care through advanced predictive modeling.

Main Methods:

  • Applied five ML algorithms (SVM, KNN, LR, RF, XGBoost) and a stacked ensemble to a Kaggle dataset (n=2105).
  • Data included demographics, medical history, lifestyle, clinical symptoms, and cognitive/functional assessments.
  • Feature selection (SBE) and interpretation (SHAP, LIME) were performed on the best-performing Random Forest model.

Main Results:

  • The Random Forest model with SBE achieved 93% accuracy, precision, recall, and F1-score, with an AUC of 0.97.
  • SHAP and LIME identified UPDRS scores, cognitive impairment, functional assessment, and motor symptoms as key predictors.
  • XAI techniques successfully enhanced the interpretability of the predictive model.

Conclusions:

  • An interpretable Random Forest model effectively predicts Parkinson's Disease.
  • Integrating ML and XAI significantly enhances clinical decision-making and diagnostic timing.
  • This approach supports personalized patient care and improves management of PD.